Clinical Trials Logo

Seach Results for — “hypothyroidism”

Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance

Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance

The aim of the study is the effect of lifestyle modification and metformin on hypothyroidism with insulin resistance

NCT06096454 — Insulin Resistance
Status: Not yet recruiting
http://inclinicaltrials.com/insulin-resistance/NCT06096454/

Pattern of Congenital Hypothyroidism in Newborns.

Pattern of Congenital Hypothyroidism in Newborns in Sidi-Galal Clinic Assiut Governorate.

1. Study the pattern of congenital hypothyroidism in newborns after positive newborn screening results. 2. Assess the characteristics of the cases (permanent congenital hypothyroidism and transient neonatal hyperthyrotopinemia).

NCT06051279 — Pattern of CH
Status: Not yet recruiting
http://inclinicaltrials.com/pattern-of-ch/NCT06051279/

Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism

Letrozole Alone vs. Letrozole Plus Levothyroxine for Ovulation Induction in Infertile Women With Both (Polycystic Ovary Syndrome) PCOS and Sub-clinical Hypothyroidism.

The goal of this randomized controlled trial is to compare letrozole alone versus letrozole plus levothyroxine for ovulation induction in infertile women with both PCOS and subclinical hypothyroidism. The main questions it aims to answer are: Is letrozole plus levothyroxine superior to letrozole alone in achieving ovulation in these patients? Does combining levothyroxine with letrozole lead to higher pregnancy and live birth rates compared to letrozole alone? Participants will be randomized into two groups: Group 1 will receive letrozole only, starting at 2.5 mg daily from day 3 to 7 of the menstrual cycle. The dose will be increased up to 7.5 mg if no ovulation occurs, for a maximum treatment period of 6 months or until pregnancy is achieved. Group 2 will receive letrozole at the same doses as group 1 plus 25 mcg levothyroxine daily.

NCT06041204 — Female Infertility
Status: Recruiting
http://inclinicaltrials.com/female-infertility/NCT06041204/

Subclinical Hypothyroidism and Chronic Inflammation in PCOS

The Influence of Subclinical Hypothyroidism on Chronic Inflammation Activity in Women With Different PCOS Phenotypes

Chronic inflammation in polycystic ovary syndrome (PCOS) may be the result of dysregulation of cytokine production (due to insulin resistance, excess visceral fat and hyperandrogenemia), i.e., overproduction of pro-inflammatory factors (e.g. TNF, IL-1, IL-6) in relation to anti-inflammatory ones (IL-10). This condition may be an important link between obesity and insulin resistance, which is crucial in the etiopathogenesis of the syndrome. However, it is not known whether it results from the tendency to accumulate adipose tissue or is a feature of the syndrome itself. Concomitant endocrinopathies, i.e. obesity, dyslipidemia, insulin resistance, diabetes and thyroid diseases, may additionally influence the activity of chronic inflammation. There is no data indicating the relationship between chronic inflammation and PCOS phenotypes, the severity of metabolic disorders, ovarian reserve and the influence of thyroid function on its activity in PCOS.

NCT05842096 — PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Status: Recruiting
http://inclinicaltrials.com/pcos-polycystic-ovary-syndrome-of-bilateral-ovaries/NCT05842096/

Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism

A Phase 2, Multicenter, Non-Randomized, Open-Label, Single Arm, Self-controlled Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism

This is a non-randomized, open-label, single arm, self-controlled study of XP-8121 (levothyroxine sodium) to determine a target dose conversion factor from stably dosed oral levothyroxine to XP-8121 (levothyroxine sodium) in patients with hypothyroidism and to assess the safety and tolerability of XP-8121(levothyroxine sodium) after once weekly subcutaneous injections. This study includes the following periods: Screening, Titration Period, and Maintenance Period. The study will conclude with an End of Maintenance Visit or Early Termination (ET) Visit.

NCT05823012 — Hypothyroidism
Status: Active, not recruiting
http://inclinicaltrials.com/hypothyroidism/NCT05823012/

NAFLD in Patient of Hypothyroidism

Early Predictors of NAFLD in Patient of Hypothyroidism

Nonalcoholic fatty liver disease (NAFLD) is the most important chronic liver disease in the western world, affecting almost 30% of the general population. Moreover, the prevalence of NAFLD can be higher in type 2 diabetic patients and obese patients, affecting up to 90% of people with a body mass index higher than 40 kg/m2. NAFLD is also the most rapidly increasing cause of hepatic cirrhosis requiring hepatic transplantation in the future. The pathophysiology of NAFLD is complex and involves multiple hits, but the principal contributing factor to its development is hepatic lipid accumulation, which leads to hepatic insulin resistance

NCT05813301 — NAFLD
Status: Not yet recruiting
http://inclinicaltrials.com/nafld/NCT05813301/

Effect of Acupuncture and Low Caloric Diet on Primary Hypothyroidism and Irregular Menstruation in Infertile Women

Effect of Acupuncture and Low Caloric Diet on Primary Hypothyroidism and Irregular Menstruation in Infertile Women

the goal of this randomize clinical trial is to compare in 60 infertile women with hypothyroidism. selected from national Nutritional institute out clinic. the main question it aims to answer is: • There an effect of acupuncture and low caloric diet on primary hypothyroidism and irregular menstruation in infertile women. all participants were received• thyroxine tablets (levothyroxine) • a low caloric diet regime. researchers compared study group (30 infertile women with hypothyroidism) to see the effect of acupuncture sections on hypothyroidism.

NCT05804149 — Acupuncture
Status: Completed
http://inclinicaltrials.com/acupuncture/NCT05804149/

Baduanjin Exercising Effects on Sub-clinical Hypothyroidism and Cognitive Problems

Baduanjin Exercising Effects on Women With Hypothyroidism and Cognitive Problems

Females with sub-clinical hypothyroidism may exhibit frequent cognitive problems especially if they are elderly

NCT05803967 — Cognitive Impairment
Status: Recruiting
http://inclinicaltrials.com/cognitive-impairment/NCT05803967/

Screening of Subclinical Hypothyroidism in Pregnant Women

Prevalence of Sub-clinical Hypothyroidism Among Pregnant Women During First Trimester: Cross Sectional Study.

this study may help the physicians to evaluate the practice of universal screening of sub-clinical hypothyroidism and thyroid-stimulating hormone level. Detection of sub-clinical hypothyroidism early in pregnancy through thyroid-stimulating hormone sampling in the first trimester will allow achieving proper management and better maternal and neonatal outcome of these patients.

NCT05801822 — Subclinical Hypothyroidism
Status: Not yet recruiting
http://inclinicaltrials.com/subclinical-hypothyroidism/NCT05801822/

Subclinical Hypothyroidism and Normogonadotropic Anovulation

Subclinical Hypothyroidism and Ovarian Reserve Indices in Women With Normogonadotropic Anovulation

Thyroid hormones (TH) can modify the functioning of the hypothalamic-pituitary-ovarian axis, affecting the functions of granulosa cells and the development and apoptosis of preantral follicles. TH receptors are present within the oocytes, and TH and anti-thyroid antibodies (ATA) are present in the follicular fluid. Improper thyroid function can cause ovulation disorders, luteal phase failure, impaired endometrial receptivity and result in implantation failures and recurrent miscarriages. While overt hypothyroidism is treated to improve fertility, the effect of subclinical hypothyroidism (SCH) and the presence of circulating ATAs on fertility and obstetric outcomes is uncertain and data on ovarian reserve rates are conflicting. Among the causes of ovulation disorders (group II according to the WHO classification), polycystic ovary syndrome (PCOS) dominates, found in 3-15% of women of reproductive age, and the remaining group of causes is the so-called Hypothalamic-Pituitary-Ovarian Axis Dysfunction (HPOD). The exact etiology of both entities is unknown.

NCT05782725 — Polycystic Ovary Syndrome
Status: Completed
http://inclinicaltrials.com/polycystic-ovary-syndrome/NCT05782725/